H

Hugel Inc
KOSDAQ:145020

Watchlist Manager
Hugel Inc
KOSDAQ:145020
Watchlist
Price: 271 000 KRW -2.34% Market Closed
Market Cap: 3T KRW
Have any thoughts about
Hugel Inc?
Write Note

Hugel Inc
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hugel Inc
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
H
Hugel Inc
KOSDAQ:145020
Income from Continuing Operations
â‚©119.4B
CAGR 3-Years
20%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Income from Continuing Operations
â‚©320.9B
CAGR 3-Years
-19%
CAGR 5-Years
7%
CAGR 10-Years
10%
SK Bioscience Co Ltd
KRX:302440
Income from Continuing Operations
â‚©22.3B
CAGR 3-Years
-12%
CAGR 5-Years
20%
CAGR 10-Years
N/A
Green Cross Corp
KRX:006280
Income from Continuing Operations
-â‚©22.5B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Income from Continuing Operations
â‚©90.8B
CAGR 3-Years
28%
CAGR 5-Years
47%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Income from Continuing Operations
-â‚©3.6B
CAGR 3-Years
34%
CAGR 5-Years
17%
CAGR 10-Years
N/A
No Stocks Found

Hugel Inc
Glance View

Market Cap
3T KRW
Industry
Biotechnology

Hugel, Inc. engages in the manufacture and sale of biopharmaceuticals based on clostridium botulinum. The company is headquartered in Chuncheon, Gangwon-Do. The company went IPO on 2015-12-24. The firm's product portfolio consists of botulinum toxins which used for treatment of benign essential blepharospasm and temporary improvement of moderate to severe glabellar lines including 50 unit types, 100 unit types and 200unit types; hyaluronic acid (HA) fillers which used for temporary removal of facial wrinkles including the chaeum premium No.1, the chaeum premium No.2, the chaeum premium No.3m the chaeum premium No.4, the chaeum MID 20A, the chaeum DEEP 20A, the chaeum SUB-Q 20A and the chaeum VOLUS 20A; wellages, blue roses and other cosmetics. The firm sells its products in domestic and overseas markets.

Intrinsic Value
251 806.3 KRW
Overvaluation 7%
Intrinsic Value
Price
H

See Also

What is Hugel Inc's Income from Continuing Operations?
Income from Continuing Operations
119.4B KRW

Based on the financial report for Sep 30, 2024, Hugel Inc's Income from Continuing Operations amounts to 119.4B KRW.

What is Hugel Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
17%

Over the last year, the Income from Continuing Operations growth was 44%. The average annual Income from Continuing Operations growth rates for Hugel Inc have been 20% over the past three years , 17% over the past five years .

Back to Top